Discover investment opportunities in Life Science Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Life Science Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Life Science Stocks using our Smart AI Filter.
7 stocks found for "Life Science Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.82 Risk measure | ±36.3% Price volatility | 21.6 Valuation | 0.00% Annual yield | |||
0.37 Risk measure | ±22.9% Price volatility | 21.1 Valuation | 0.52% Annual yield | |||
0.62 Risk measure | ±51.3% Price volatility | 71.6 Valuation | 0.00% Annual yield | |||
1.19 Risk measure | ±37.2% Price volatility | 15.3 Valuation | 0.76% Annual yield | |||
1.50 Risk measure | ±64.8% Price volatility | -8.0 Valuation | 0.00% Annual yield | |||
0.89 Risk measure | ±41.9% Price volatility | 22.8 Valuation | 0.00% Annual yield | |||
1.24 Risk measure | ±27.6% Price volatility | 13.6 Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Illumina Inc. ILMN is currently in Phase 17 of its 18-phase Adhishthana Cycle on the weekly chart. A detailed structural analysis using the Adhishthana Principles reveals deeper issues that go beyond short-term price action and offers compelling reasons why this stock should be avoided.
Read moreInvestors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Qiagen (QGEN) or Exact Sciences (EXAS). But which of these two stocks presents investors with the better value opportunity right now?
Read moreQ: What competitive advantages do life science companies like ILMN and VRTX have?
A: Companies like ILMN (Illumina) and VRTX (Vertex Pharmaceuticals) often have extensive R&D capabilities and strong patent portfolios, providing competitive edges in genomics and innovative therapies, respectively. These advantages can lead to robust pipelines and sustained market leadership.
Q: Are dividend yields from life science firms like PFE and AMGN stable?
A: Pfizer (PFE) and Amgen (AMGN) usually offer stable dividend yields, benefiting from strong cash flows and mature product lines. However, investors should review each company's financials and consider the impact of product cycles or regulations on dividend sustainability.
Q: How do economic downturns typically impact companies like REGN and BIIB in the life sciences sector?
A: During economic downturns, companies like Regeneron (REGN) and Biogen (BIIB) may experience varied impacts. Demand for essential therapies remains steady, but funding for new projects might slow. Historical performance suggests resilience due to healthcare's non-cyclical nature.
Q: What growth prospects do companies like MRNA and GILD have in the biotech sector?
A: Moderna (MRNA) and Gilead Sciences (GILD) are fueled by strong pipelines, focusing on vaccines and antiviral treatments. Investors consider ongoing clinical trials and regulatory approvals to assess growth potential, as successful innovations can drive substantial revenue growth.
Q: Do life science firms like ABT provide good value investments?
A: Abbott Laboratories (ABT), with its diverse revenue streams across diagnostics, medical devices, and nutrition, often appeals to value investors. Analyzing P/E ratios and market trends helps evaluate if current stock prices align with long-term growth expectations.
Q: How do geopolitical factors affect companies like IQV and PFE in the life sciences industry?
A: Firms like IQVIA (IQV) and Pfizer (PFE) face geopolitical risks, including regulatory changes and trade policies. These can influence supply chains and market access, impacting international operations and requiring strategic adaptations to mitigate risks.